Nagy P - Search Results

1

Identification of Bacterial Metabolites Modulating Breast Cancer Cell Proliferation and Epithelial-Mesenchymal Transition.

Ujlaki G, Kovács T, Vida A, Kókai E, Rauch B, Schwarcz S, Mikó E, Janka E, Sipos A, Hegedűs C, Uray K, Nagy P, Bai P. Ujlaki G, et al. Among authors: nagy p. Molecules. 2023 Aug 5;28(15):5898. doi: 10.3390/molecules28155898. Molecules. 2023. PMID: 37570868 Free PMC article.

2

Chemoprevention of Breast Cancer by Dietary Polyphenols.

Mocanu MM, Nagy P, Szöllősi J. Mocanu MM, et al. Among authors: nagy p. Molecules. 2015 Dec 17;20(12):22578-620. doi: 10.3390/molecules201219864. Molecules. 2015. PMID: 26694341 Free PMC article. Review.

3

Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance.

Barok M, Isola J, Pályi-Krekk Z, Nagy P, Juhász I, Vereb G, Kauraniemi P, Kapanen A, Tanner M, Vereb G, Szöllösi J. Barok M, et al. Among authors: nagy p. Mol Cancer Ther. 2007 Jul;6(7):2065-72. doi: 10.1158/1535-7163.MCT-06-0766. Mol Cancer Ther. 2007. PMID: 17620435

4

Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer.

Pályi-Krekk Z, Barok M, Isola J, Tammi M, Szöllosi J, Nagy P. Pályi-Krekk Z, et al. Among authors: nagy p. Eur J Cancer. 2007 Nov;43(16):2423-33. doi: 10.1016/j.ejca.2007.08.018. Eur J Cancer. 2007. PMID: 17911008

5

Epigallocatechin-3-O-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines.

Filippi A, Picot T, Aanei CM, Nagy P, Szöllősi J, Campos L, Ganea C, Mocanu MM. Filippi A, et al. Among authors: nagy p. Int J Food Sci Nutr. 2018 Aug;69(5):584-597. doi: 10.1080/09637486.2017.1401980. Epub 2017 Nov 21. Int J Food Sci Nutr. 2018. PMID: 29157036

6

Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer.

Costea T, Nagy P, Ganea C, Szöllősi J, Mocanu MM. Costea T, et al. Among authors: nagy p. Int J Mol Sci. 2019 Mar 1;20(5):1062. doi: 10.3390/ijms20051062. Int J Mol Sci. 2019. PMID: 30823649 Free PMC article. Review.

7

Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.

Barok M, Balázs M, Nagy P, Rákosy Z, Treszl A, Tóth E, Juhász I, Park JW, Isola J, Vereb G, Szöllosi J. Barok M, et al. Among authors: nagy p. Cancer Lett. 2008 Feb 18;260(1-2):198-208. doi: 10.1016/j.canlet.2007.10.043. Epub 2007 Dec 21. Cancer Lett. 2008. PMID: 18096313

8

The dipole potential correlates with lipid raft markers in the plasma membrane of living cells.

Kovács T, Batta G, Zákány F, Szöllősi J, Nagy P. Kovács T, et al. Among authors: nagy p. J Lipid Res. 2017 Aug;58(8):1681-1691. doi: 10.1194/jlr.M077339. Epub 2017 Jun 12. J Lipid Res. 2017. PMID: 28607008 Free PMC article.

9

Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.

Nagy P, Vereb G, Sebestyén Z, Horváth G, Lockett SJ, Damjanovich S, Park JW, Jovin TM, Szöllosi J. Nagy P, et al. J Cell Sci. 2002 Nov 15;115(Pt 22):4251-62. doi: 10.1242/jcs.00118. J Cell Sci. 2002. PMID: 12376557

10

Associations of ErbB2, beta1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell lines.

Mocanu MM, Fazekas Z, Petrás M, Nagy P, Sebestyén Z, Isola J, Tímár J, Park JW, Vereb G, Szöllosi J. Mocanu MM, et al. Among authors: nagy p. Cancer Lett. 2005 Sep 28;227(2):201-12. doi: 10.1016/j.canlet.2005.01.028. Cancer Lett. 2005. PMID: 16112423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,279 results

Search Page

Filters